Publication Year

Dougherty C, Friedman BW, Aurora S, Bariahtaris S, Shrewsbury S, Baker-Wagner M, Sacks N, Kautz S, Cyr P. INP104 reduces self-reported ED and urgent care in patients with episodic migraine. Presentation at Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Virtual, April 2021.

Sheshadri A, Sacks NC, Healey B, Raza S, Cyr P, Boerner G, Huang HJ. A descriptive analysis of costs and healthcare resource use in patients with bronchiolitis obliterans syndrome (BOS) following lung transplantation. Poster presentation, ISPOR 25th Annual International Meeting, May 2021.

Wallace E, Sacks NC, Cyr P, Baker-Wagner M. An observational cohort analysis on the economic impact of chronic kidney disease in patients with fabry disease. Poster presentation, ISPOR Annual International Meeting, Virtual, May 2021.

Sacks NC, Healey B, Cyr PL, Slocomb T, James E, Beggs A, Graham RJ. Healthcare resource use and expenditures in patients with x-linked myotubular myopathy (XLMTM). Poster presentation, ISPOR 25th Annual International Meeting, Orlando, FL, April 2021.

Panattoni L, Hernandez J, Liu Y, Sacks NC, Higham R, Stephenson B, Armstrong A. Initial treatment patterns for newly diagnosed, commercially insured patients with psoriasis. Poster presentation, ISPOR, April 2021.

Yin W, Nie Z, Dingley K, Trzoss M, Krilov G, Marshall N et al. 2021. Characterization of potent paracaspase MALT1 inhibitors for hematological malignancies. Blood 138 (Supplement 1):1187; doi: 10.1182/blood-2021-153159.

Rehorn MR, Sacks NM, Cyr PL, Emden, MR, Sherwood R, Pokorney SD. Rates of catheter ablation for paroxysmal supraventricular tachycardia in the United States. J Am Coll Cardiol 77 (18-Sup1):330. Poster Contribution, American College of Cardiology, 2021.

Dean R, Jensen IS, Cyr PL, Miller B, Maru B, Sproule DM, Feltner DE, et al. 2021. An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER). J Mark Access Health Pol 9(1):1889841; doi: 10.1080/20016689.2021.1889841.

Kimzey A, Mease K, Mounho-Zamora B, Wood M. 2021. 13. Biosimilar products—A review of past and current regulatory approval standards for preclinical safety studies. In: Translational Medicine: Optimising Preclinical Safety Evaluation of Biopharmaceuticals. CRC Press: Boca Raton, FL.

Jaeschke H, Murray FJ, Monnot AD, Jacobson-Kram D, Cohen SM, Hardisty JF, Atillasoy E… Wikoff D, et al. 2021. Assessment of the biochemical pathways for acetaminophen toxicity: Implications for its carcinogenic hazard potential. Regul Toxicol Pharmacol 120(March):104859; doi: 10.1016/j.yrtph.2020.104859. PMID: 33388367.

Alexander W, Jensen I, Hathway J, Srivastava K, Cyr P, Batt K. Economic IMPACT of utilizing eptacog beta for the on-demand treatment of bleeding events among hemophilia patients with inhibitors. Abstract PBI11, ISPOR 2021 Annual International Meeting.

Oh E, Yi J, Pittman C, Price C, Nieman C. Considering the technological and sensory needs of patients with cognitive impairment in the era of telehealth. Presentation to American Auditory Society Annual Conference; https://doi.org/10.1093/geroni/igab046.326, 2021.

Houck KA, Patlewicz G, Richard A, Williams AJ, Smeltz M, Clifton, MS, Wetmore B, Medvedev A, Makarov SS. 2021. Bioactivity profiling of per- and polyfluoroalkyl substances identifies potential toxicity pathways related to molecular structure. Toxicology 457(June 15):152789; doi: 10.1016/j.tox.2021.152789. PMID: 33887376.

Reynolds JI, Saparastzardroudi M, Alan J, Sing K, Lee S, Johnson BP. WormPlate: A micromilled microfluidic device for studying lipid signaling in C. elegans. Poster presented at Biomedical Engineering Society Annual Meeting, Virtual, 2021.

Bolt A, Reynolds JI, Saparastzardroudi M, Alan J, Sing K, Lee S, Johnson BP. Rapid prototyping of microfluidic devices using micromachining. Mid-Michigan Symposium for Undergraduate Research Experiences, East Lansing, MI, 2021.

Pang F, Dean R, Jensen I, Olaye A, Miller B. The cost-effectiveness of OTL-200 for the treatment of metachromatic leukodystrophy (MLD) in the US. Abstract PRO30, ISPOR 2021.

Prizada W, Khan S, Maharjan S, Jacobellis M, Sasoun S. Observing planarian regeneration upon exposure to AMPA. Stony Brook University Undergraduate Research and Creative Activities (URECA), Stony Brook, NY, 2021.

Jacobellis M, Khan S, Prizada W, Maharjan S, Sasoun S, Girgis M, Byrne S. AMPA (α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid) affects the regeneration rate of the planarian (Girardia tigrina). Stony Brook University Undergraduate Research and Creative Activities (URECA), Stony Brook, NY, 2021.

Jacobellis M, Blaby-Haas C. Selective pressure responsible for pathway evolution of arsenic tolerance in bioenergy algae. Science Undergraduate Laboratory Internship (SULI) Presentations, Brookhaven National Laboratory, Upton, NY, 2021.

Robison TW. How many doses of an Ames-positive/mutagenic (DNA reactive) drug can be safely administered to healthy subjects? Genetic Toxicology Association, 2021.